Huimin Du

Huimin Du

Auto-generated profile, based on publicly available information

Huimin Du

Department of Oncology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2024 in Cancer Immunology Research
Verified
Journal Article
Open access
JSJiazheng Sun
Jiazheng Sun
PWPin Wang
Pin Wang
ZYZiying Yi
Ziying Yi
YWYushen Wu
Yushen Wu
WXWei Yu xian
Wei Yu xian
HLHongzhong Li
Hongzhong Li
The limited infiltration of CD8+ T cells in tumors hampers the effectiveness of T cell–based immunotherapy, yet the mechanisms that limit tumor infiltration by CD8+ T cells remain unclear. Through bulk RNA sequencing of human tumors, we identified a strong correlation between WNT7A expression and reduced CD8+ T-cell infiltration. Further investigation demonstrated that inhibiting WNT7A substantially enhanced MHC-I expression on tumor cells. Mechanistically, WNT7A inhibition inactivated the Wnt/β-catenin signaling pathway and thus resulted in reduced physical interaction between β-catenin and p65 in the cytoplasm, which increased the nuclear translocation of p65 and activated the NF-κB pathway, ultimately promoting the transcription of genes encoding MHC-I molecules. We found that our lead compound, 1365-0109, disrupted the protein–protein interaction between WNT7A and its receptor FZD5, resulting in the upregulation of MHC-I expression. In murine tumor models, both genetic and pharmaceutical suppression of WNT7A led to increased MHC-I levels on tumor cells, and consequently enhanced the infiltration and functionality of CD8+ T cells, which bolstered antitumor immunity and improved the effectiveness of immune checkpoint blockade therapy. These findings have elucidated the intrinsic mechanisms of WNT7A-induced immune suppression, suggesting that therapeutic interventions targeting WNT7A hold promise for enhancing the efficacy of immunotherapy.

1 January 2022
Verified
Conference Paper
Closed access
YCYue Chen
Yue Chen
HDHuimin Du
Huimin Du
LCLibo Chang
Libo Chang
Mixed-precision quantization can compress the size of the Convolution Neural Networks (CNNs) without reducing the accuracy of the network. A fixed bit width CNN accelerator needs to match the largest bit width in mixed- precision CNNs, which cause a huge waste of resource. In order to match the multiple quantization bit width of mixed- precision CNNs, we propose a reconfigurable microprocessing element (RmPE) that supports multi-precision parallel multiplication and addition operations. After testing, when the CNN accelerator with RmPE infers mixed-precision VGG-16 and ResNet-50 on the Ultra96-V2 platform, the computing performance of the accelerator reaches 216.6 GOPS and 214 GOPS, and the computing efficiency of the accelerator reaches 0.63 GOPS/DSP and 0.64 GOPS/DSP. Compared with the fixed-bit width CNN accelerator, our accelerator has higher computational efficiency.

4 March 2025
Verified
Other
Open access
JSJiazheng Sun
Jiazheng Sun
PWPin Wang
Pin Wang
ZYZiying Yi
Ziying Yi
YWYushen Wu
Yushen Wu
WXWei Yu xian
Wei Yu xian
HLHongzhong Li
Hongzhong Li
Figure S2 Blocking WNT7A leads to an increase in MHC-I expression.

4 March 2025
Verified
Other
Open access
JSJiazheng Sun
Jiazheng Sun
PWPin Wang
Pin Wang
ZYZiying Yi
Ziying Yi
YWYushen Wu
Yushen Wu
WXWei Yu xian
Wei Yu xian
HLHongzhong Li
Hongzhong Li
Figure S4 Inhibition of WNT7A leads to the upregulation of MHC-I via the NF-κB pathway.

4 March 2025
Verified
Other
Open access
JSJiazheng Sun
Jiazheng Sun
PWPin Wang
Pin Wang
ZYZiying Yi
Ziying Yi
YWYushen Wu
Yushen Wu
WXWei Yu xian
Wei Yu xian
HLHongzhong Li
Hongzhong Li
Figure S3 WNT7A blockage inhibits tumor growth and enhances anti-tumor immunity.

4 March 2025
Verified
Other
Open access
JSJiazheng Sun
Jiazheng Sun
PWPin Wang
Pin Wang
ZYZiying Yi
Ziying Yi
YWYushen Wu
Yushen Wu
WXWei Yu xian
Wei Yu xian
HLHongzhong Li
Hongzhong Li
Figure S5 Blocking WNT7A synergizes with ICB.